Xtant Medical to Announce Q2 2025 Earnings on August 12, 2025.
ByAinvest
Wednesday, Aug 6, 2025 3:10 am ET1min read
XTNT--
Investors can access the call via phone or webcast, with a replay available on the company's website. The announcement provides insights into the company's performance and strategic direction. Details of the conference call include a domestic dial-in number (877-545-0523), an international dial-in number (973-528-0016), and a passcode (482755). The webcast link is available at [Xtant Medical Q2 2025 Financial Results](https://www.webcaster4.com/Webcast/Page/3039/52698).
Xtant Medical Holdings, Inc. is dedicated to honoring the gift of donation, allowing patients to live full and complete lives. The company focuses on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. The company operates with the highest integrity to serve its customers.
References
[1] https://www.nasdaq.com/press-release/xtant-medical-announce-second-quarter-2025-financial-results-august-12-2025-2025-08
[2] https://finance.yahoo.com/news/xtant-medical-announce-second-quarter-120000784.html
[3] https://www.stocktitan.net/news/XTNT/xtant-medical-to-announce-second-quarter-2025-financial-results-on-11qn3tksxap9.html
Xtant Medical Holdings will announce Q2 2025 financial results on August 12, 2025. CEO Sean Browne and CFO Scott Neils will host a conference call at 8:30 AM ET. Investors can access the call via phone or webcast, with a replay available on the company's website. The announcement provides insights into the company's performance and strategic direction.
Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company specializing in surgical solutions for spinal, orthopedic, and woundcare disorders, has scheduled the release of its second quarter 2025 financial results for August 12, 2025, before market open. The company will host a conference call at 8:30 AM ET on the same day, featuring President and CEO Sean Browne and CFO Scott Neils.Investors can access the call via phone or webcast, with a replay available on the company's website. The announcement provides insights into the company's performance and strategic direction. Details of the conference call include a domestic dial-in number (877-545-0523), an international dial-in number (973-528-0016), and a passcode (482755). The webcast link is available at [Xtant Medical Q2 2025 Financial Results](https://www.webcaster4.com/Webcast/Page/3039/52698).
Xtant Medical Holdings, Inc. is dedicated to honoring the gift of donation, allowing patients to live full and complete lives. The company focuses on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. The company operates with the highest integrity to serve its customers.
References
[1] https://www.nasdaq.com/press-release/xtant-medical-announce-second-quarter-2025-financial-results-august-12-2025-2025-08
[2] https://finance.yahoo.com/news/xtant-medical-announce-second-quarter-120000784.html
[3] https://www.stocktitan.net/news/XTNT/xtant-medical-to-announce-second-quarter-2025-financial-results-on-11qn3tksxap9.html
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet